AstraZeneca continues yard-sale strategy with $538M Seroquel rights deal
admin 8th May 2018 Uncategorised 0AstraZeneca is back at it again with its asset sales. The company offloaded certain Seroquel rights to Luye Pharma for up to $538 million.
More: AstraZeneca continues yard-sale strategy with 8M Seroquel rights deal
Source: fierce